LOUIS L ZUEGNER 3RD
Accountancy in Flemington, NJ
License number
New Jersey 20CC00579400
Issued Date
Aug 25, 1971
Expiration Date
Dec 31, 2017
Category
Accountancy
Type
Certified Public Accountant
Address
Address
Flemington, NJ
Professional information
Biaryl Substituted Triazoles As Sodium Channel Blockers
US Patent:
7326726, Feb 5, 2008
Filed:
Mar 12, 2004
Appl. No.:
10/799230
Inventors:
Prasun K. Chakravarty - Edison NJ, US
Louis L. Zuegner III, legal representative - Flemington NJ, US
Brenda Palucki - Hillsborough NJ, US
Min K. Park - Whippany NJ, US
William H. Parsons - Belle Mead NJ, US
Bishan Zhou - Hoboken NJ, US
Louis L. Zuegner III, legal representative - Flemington NJ, US
Brenda Palucki - Hillsborough NJ, US
Min K. Park - Whippany NJ, US
William H. Parsons - Belle Mead NJ, US
Bishan Zhou - Hoboken NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31/41, C07D 249/08
US Classification:
514359, 5482694
Abstract:
Biaryl substituted triazole compounds represented by Formula I, II or III, or pharmaceutically acceptable salts thereof, and a process for making such compounds and salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, sodium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, epilepsy, irritable bowel syndrome, depression, anxiety, multiple sclerosis, and bipolar disorder, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds. A method of administering local anesthesia comprises administering an effective amount of a compound of the instant invention, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier.
Biaryl Substituted Triazoles As Sodium Channel Blockers
US Patent:
2008017, Jul 17, 2008
Filed:
Jan 30, 2008
Appl. No.:
12/011967
Inventors:
Prasun K. Chakravarty - Edison NJ, US
Michael H. Fisher - Flemington NJ, US
Louis L. Zuegner - Flemington NJ, US
William H. Parsons - Belle Mead NJ, US
Brenda Palucki - Hillsborough NJ, US
Bishan Zhou - Edison NJ, US
Min K. Park - Whippany NJ, US
Michael H. Fisher - Flemington NJ, US
Louis L. Zuegner - Flemington NJ, US
William H. Parsons - Belle Mead NJ, US
Brenda Palucki - Hillsborough NJ, US
Bishan Zhou - Edison NJ, US
Min K. Park - Whippany NJ, US
International Classification:
A61K 31/4196, C07D 249/08, A61P 23/02, A61P 25/04
US Classification:
514383, 5482668
Abstract:
Biaryl substituted triazole compounds represented by Formula I, II or III, or pharmaceutically acceptable salts thereof, and a process for making such compounds and salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, sodium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, epilepsy, irritable bowel syndrome, depression, anxiety, multiple sclerosis, and bipolar disorder, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds. A method of administering local anesthesia comprises administering an effective amount of a compound of the instant invention, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier.
Substituted Triazoles As Sodium Channel Blockers
US Patent:
2006002, Jan 26, 2006
Filed:
Nov 10, 2004
Appl. No.:
10/985592
Inventors:
Min Park - Whippany NJ, US
Prasun Chakravarty - Edison NJ, US
Bishan Zhou - Hoboken NJ, US
Edward Gonzalez - Iselin NJ, US
Hyun Ok - Colonia NJ, US
Brenda Palucki - Hillsborough NJ, US
William Parsons - Belle Mead NJ, US
Rosemary Sisco - Old Bridge NJ, US
Michael Fisher - Ringoes NJ, US
Louis Zuegner - Flemington NJ, US
Prasun Chakravarty - Edison NJ, US
Bishan Zhou - Hoboken NJ, US
Edward Gonzalez - Iselin NJ, US
Hyun Ok - Colonia NJ, US
Brenda Palucki - Hillsborough NJ, US
William Parsons - Belle Mead NJ, US
Rosemary Sisco - Old Bridge NJ, US
Michael Fisher - Ringoes NJ, US
Louis Zuegner - Flemington NJ, US
International Classification:
A61K 31/4196, C07D 403/02
US Classification:
514383000, 548266200
Abstract:
Substituted triazole compounds represented by Formula I, II or III, or pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, sodium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, migraine, headache pain, migraine headache, epilepsy, irritable bowel syndrome, diabetic neuropathy, multiple sclerosis, manic depression and bipolar disorder, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds. A method of administering local anesthesia comprises administering an effective amount of a compound of the instant invention, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier.